13 results
management diabetes endocrinology diagnosis table treatment cardiology comparison vasopressors criticalcare differential inhibitors medications abscess agonists algorithm antiarrhythmics cardiomyopathy chf classes
Vasopressors and Inotropes - Pharmacology Summary Vasopressors Phenylephrine (alpha-1) • Increases BP, SVR • Risk of reflex bradycardia
- Pharmacology ... Summary Vasopressors ... • Higher doses cause ... #Pharmacology # ... Summary #management
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... side effects (e.g ... #Summary #DM2 #
Vasopressors Table Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Receptor, Heart Rate/Inotropy ... Resistance, Main Uses ... 0.375-0.75 mcg/kg ... Properties #Table #Pharmacology ... Management #Comparison #Inotropes
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Summary Mechanisms ... mL/minute/1.73 m2 ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... side effects (e.g ... not definitively cause ... #Summary #DM2 #
Common Vasopressors and Inotropes Norepinephrine (NE) - Indication: Distributive shock (1st line for septic shock), Cardiogenic shock
Vasopressors and Inotropes ... is not desired (e.g ... Bradyarrhythmias, Some cases ... #Vasopressors #Inotropes ... comparison #table #pharmacology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... 0.3-0.6 units/kg ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology
Peripartum Cardiomyopathy - Summary 1. Definition • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... exclude other causes ... cardiomyopathy (e.g ... hemodynamics (e.g ... therapy, including inotropes
Antiarrhythmics Pharmacology Summary Cardiac Conduction Phases: Phase 0 - Ventricular Depolarization: • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Summary Cardiac ... force (negative inotropy ... Antiarrhythmics #Pharmacology ... Classification #Classes
No results found for "PocketCard ekg causes collateral pharmacology summary dm2 inotropes"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PocketCard #ekg #causes #collateral #pharmacology #summary #dm2 #inotropes